Research on the Significance of Thymosin Α1 for Infection Risk and Prognosis in Elderly Lung Cancer Patients Received Chemotherapy

qiao dan,wang zhiyu,wen xiaoting,lu yaohong,zhao hui
DOI: https://doi.org/10.11735/j.issn.1004-0242.2015.08.A014
2015-01-01
Abstract:[Purpose] To evaluate significance of thymosin α1(Tα1) for infection risk and prognosis in elderly lung cancer patients received chemotherapy. [Methods] A total of 198 cases with lung cancer over 60-years-old received platinum-based chemotherapy were classified into the control group(n =112) and the observation group with additional thymosin α1(n =86) according to treatment schemes. Changes in cellular immunology function,infection rates and overall survival rates were compared between the two groups. [Results] After treatment,the levels of serum CD3+,CD4+and NK significantly increased,CD8+significantly decreased in the observation group comparing with the control group and the pretreatment levels(P<0.05). The infection rates of observation group were far lower than the control group(P<0.05). Multivariate Logistic regression analysis showed thymosin α1 was protective factor(OR=0.45,95%CI:0.23~0.89,P=0.021). The median survival time between observation group and control group had no statistical difference(14.36 months vs 13.06 months,P>0.05). Patients with infection in observation group had a better prognosis than those in control group(P<0.05). [Conclusion] Thymosin α1 can effectively decrease the infection rates and infection-related death rates of elderly lung cancer patients who received platinum-based chemotherapy.
What problem does this paper attempt to address?